Role of metal ions in the abeta oligomerization in Alzheimer's disease and in other neurological disorders.

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Current Alzheimer Research

• Publication date

  2008-11-30

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.2174/156720508786898479PMID 19075576
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Potential pathogenic role of beta-amyloid(1-42)-aluminum complex in Alzheimer's disease.

  2008cited by this paper
• Characterization of copper interactions with alzheimer amyloid beta peptides: identification of an attomolar-affinity copper binding site on amyloid beta1-42.

  2008cited by this paper
• Intracellular amyloid-beta in Alzheimer's disease.

  2007cited by this paper
• Accelerating amyloid-beta fibrillization reduces oligomer levels and functional deficits in Alzheimer disease mouse models.

  2007cited by this paper
• Femtomole immunodetection of synthetic and endogenous amyloid-β oligomers and its application to Alzheimer’s disease drug candidate screening

  2007cited by this paper
• Mechanisms of ataxin-3 misfolding and fibril formation: kinetic analysis of a disease-associated polyglutamine protein.

  2007cited by this paper
• Soluble protein oligomers as emerging toxins in alzheimer's and other amyloid diseases

  2007cited by this paper
• Small Molecule Inhibitors of Aggregation Indicate That Amyloid β Oligomerization and Fibrillization Pathways Are Independent and Distinct*

  2007cited by this paper
• Destabilization of non-pathological variants of ataxin-3 by metal ions results in aggregation/fibrillogenesis.

  2007cited by this paper
• Combining the rapid MTT formazan exocytosis assay and the MC65 protection assay led to the discovery of carbazole analogs as small molecule inhibitors of Abeta oligomer-induced cytotoxicity.

  2007cited by this paper
• A specific amyloid-beta protein assembly in the brain impairs memory.

  2006cited by this paper
• Temporal profile of amyloid-beta (Abeta) oligomerization in an in vivo model of Alzheimer disease. A link between Abeta and tau pathology.

  2006cited by this paper
• Metal exposure and Alzheimer's pathogenesis.

  2006cited by this paper
• Different Conformations of Amyloid β Induce Neurotoxicity by Distinct Mechanisms in Human Cortical Neurons

  2006cited by this paper
• A dynamic relationship between intracellular and extracellular pools of Abeta.

  2006cited by this paper
• A novel tricyclic pyrone compound ameliorates cell death associated with intracellular amyloid‐β oligomeric complexes

  2006cited by this paper
• Aluminum and Alzheimer's disease: A Vexata Questio between uncertain data and a lot of imagination

  2006cited by this paper
• Aluminum and other metals in Alzheimer's disease: A review of potential therapy with chelating agents

  2006cited by this paper
• Aggregation/fibrillogenesis of recombinant human prion protein and Gerstmann-Sträussler-Scheinker disease peptides in the presence of metal ions.

  2006cited by this paper
• Blood-brain barrier flux of aluminum, manganese, iron and other metals suspected to contribute to metal-induced neurodegeneration

  2006cited by this paper
• Aluminum in hippocampal neurons from humans with Alzheimer's disease.

  2006cited by this paper
• Aluminum and Alzheimer's disease: A new look

  2006cited by this paper
• Natural oligomers of the amyloid-β protein specifically disrupt cognitive function

  2005cited by this paper
• Towards a structural understanding of the fibrillization pathway in Machado-Joseph's disease: trapping early oligomers of non-expanded ataxin-3.

  2005cited by this paper
• Calcium Dysregulation and Membrane Disruption as a Ubiquitous Neurotoxic Mechanism of Soluble Amyloid Oligomers*♦

  2005cited by this paper
• Gradual Alteration of Mitochondrial Structure and Function by β-Amyloids: Importance of Membrane Viscosity Changes, Energy Deprivation, Reactive Oxygen Species Production, and Cytochrome c Release

  2005cited by this paper
• Mitochondrial Abeta: a potential focal point for neuronal metabolic dysfunction in Alzheimer's disease.

  2005cited by this paper
• Metals and amyloid‐β in Alzheimer's disease

  2005cited by this paper
• Tau pathology in Alzheimer disease and other tauopathies.

  2005cited by this paper
• Effects of aluminum on the nervous system and its possible link with neurodegenerative diseases

  2005cited by this paper
• Certain inhibitors of synthetic amyloid beta-peptide (Abeta) fibrillogenesis block oligomerization of natural Abeta and thereby rescue long-term potentiation.

  2005cited by this paper
• Aluminum-triggered structural modifications and aggregation of beta-amyloids.

  2005cited by this paper
• Nanoparticle-based detection in cerebral spinal fluid of a soluble pathogenic biomarker for Alzheimer's disease.

  2005cited by this paper
• Aluminium in Alzheimer’s disease: are we still at a crossroad?

  2004cited by this paper
• Synaptic targeting by Alzheimer's-related amyloid beta oligomers.

  2004cited by this paper
• Pathways towards and away from Alzheimer's disease

  2004cited by this paper
• The role of beta amyloid in Alzheimer's disease: still a cause of everything or the only one who got caught?

  2004cited by this paper
• Conformation-dependent antibodies target diseases of protein misfolding.

  2004cited by this paper
• Toxicity of amyloid beta peptide: tales of calcium, mitochondria, and oxidative stress.

  2004cited by this paper
• The regions of the sequence most exposed to the solvent within the amyloidogenic state of a protein initiate the aggregation process.

  2004cited by this paper
• Chronic exposure to aluminum in drinking water increases inflammatory parameters selectively in the brain

  2004cited by this paper
• Mechanism of Prion Propagation: Amyloid Growth Occurs by Monomer Addition

  2004cited by this paper
• Trace metal contamination initiates the apparent auto-aggregation, amyloidosis, and oligomerization of Alzheimer’s Aβ peptides

  2004cited by this paper
• Aluminium, iron, zinc and copper influence the in vitro formation of amyloid fibrils of Aβ42 in a manner which may have consequences for metal chelation therapy in Alzheimer's disease

  2004cited by this paper
• Protein misfolding and aggregation: new examples in medicine and biology of the dark side of the protein world.

  2004cited by this paper
• Protein aggregation and aggregate toxicity: new insights into protein folding, misfolding diseases and biological evolution

  2003cited by this paper
• Triple-transgenic model of Alzheimer's disease with plaques and tangles: intracellular Abeta and synaptic dysfunction.

  2003cited by this paper
• Increased vulnerability of brain mitochondria in diabetic (Goto-Kakizaki) rats with aging and amyloid-beta exposure.

  2003cited by this paper
• Common Structure of Soluble Amyloid Oligomers Implies Common Mechanism of Pathogenesis

  2003cited by this paper
• The role of metals in neurodegenerative processes: aluminum, manganese, and zinc.

  2003cited by this paper
• Alzheimer's disease-affected brain: Presence of oligomeric Aβ ligands (ADDLs) suggests a molecular basis for reversible memory loss

  2003cited by this paper
• Protofibrils, pores, fibrils, and neurodegeneration: separating the responsible protein aggregates from the innocent bystanders.

  2003cited by this paper
• Amyloid-beta: a chameleon walking in two worlds: a review of the trophic and toxic properties of amyloid-beta.

  2003cited by this paper
• Metal binding and oxidation of amyloid-beta within isolated senile plaque cores: Raman microscopic evidence.

  2003cited by this paper
• The metallobiology of Alzheimer's disease.

  2003cited by this paper
• In Vitro Characterization of Conditions for Amyloid-β Peptide Oligomerization and Fibrillogenesis*

  2003cited by this paper
• Copper reduction by copper binding proteins and its relation to neurodegenerative diseases

  2003cited by this paper
• Alzheimer's disease-do tauists and baptists finally shake hands?

  2002cited by this paper
• Soluble oligomers of beta amyloid (1-42) inhibit long-term potentiation but not long-term depression in rat dentate gyrus.

  2002cited by this paper
• Aluminum modulates brain amyloidosis through oxidative stress in APP transgenic mice

  2002cited by this paper
• Aluminum citrate uptake by immortalized brain endothelial cells: implications for its blood-brain barrier transport.

  2002cited by this paper
• Metal switch for amyloid formation: insight into the structure of the nucleus.

  2002cited by this paper
• The Amyloid Hypothesis of Alzheimer's Disease: Progress and Problems on the Road to Therapeutics

  2002cited by this paper
• Amyloid-beta oligomers: their production, toxicity and therapeutic inhibition.

  2002cited by this paper
• Oligomeric and Fibrillar Species of Amyloid-β Peptides Differentially Affect Neuronal Viability*

  2002cited by this paper
• Effects of aluminum on the neurotoxicity of primary cultured neurons and on the aggregation of beta-amyloid protein.

  2001cited by this paper
• β‐Amyloid inhibits integrated mitochondrial respiration 
and key enzyme activities

  2001cited by this paper
• Intraneuronal abeta-amyloid precedes development of amyloid plaques in Down syndrome.

  2001cited by this paper
• The structural basis of protein folding and its links with human disease.

  2001cited by this paper
• Treatment with a copper-zinc chelator markedly and rapidly inhibits beta-amyloid accumulation in Alzheimer's disease transgenic mice.

  2001cited by this paper
• New insights on how metals disrupt amyloid beta-aggregation and their effects on amyloid-beta cytotoxicity.

  2001cited by this paper
• Histochemically-reactive zinc in amyloid plaques, angiopathy, and degenerating neurons of Alzheimer's diseased brains.

  2000cited by this paper
• Alzheimer's disease amyloid propagation by a template-dependent dock-lock mechanism.

  2000cited by this paper
• In Situ Oxidative Catalysis by Neurofibrillary Tangles and Senile Plaques in Alzheimer’s Disease

  2000cited by this paper
• Absorption of Aluminium-26 in Alzheimer’s Disease, Measured Using Accelerator Mass Spectrometry

  2000cited by this paper
• Mechanisms of amyloidogenesis

  2000cited by this paper
• Cu(II) potentiation of alzheimer abeta neurotoxicity. Correlation with cell-free hydrogen peroxide production and metal reduction.

  1999cited by this paper
• Soluble amyloid beta peptide concentration as a predictor of synaptic change in Alzheimer's disease.

  1999cited by this paper
• Age-related hippocampal changes in Bcl-2:Bax ratio, oxidative stress, redox-active iron and apoptosis associated with aluminum-induced neurodegeneration: increased susceptibility with aging.

  1999cited by this paper
• Aqueous Dissolution of Alzheimer’s Disease Aβ Amyloid Deposits by Biometal Depletion*

  1999cited by this paper
• Diffusible, nonfibrillar ligands derived from Abeta1-42 are potent central nervous system neurotoxins.

  1998cited by this paper
• Aluminosilicate Particulate and Beta‐Amyloid in Vitro Interactions: A Model of Alzheimer Plaque Formation

  1998cited by this paper
• A method based on ICP-MS for the analysis of Alzheimer's amyloid plaques.

  1998cited by this paper
• Dramatic Aggregation of Alzheimer Aβ by Cu(II) Is Induced by Conditions Representing Physiological Acidosis*

  1998cited by this paper
• Copper, iron and zinc in Alzheimer's disease senile plaques.

  1998cited by this paper
• Is exposure to aluminum a risk factor for the development of Alzheimer disease?--No.

  1998cited by this paper
• Mechanisms of aluminum absorption in rats.

  1997cited by this paper
• Risk for neuropathologically confirmed Alzheimer's disease and residual aluminum in municipal drinking water employing weighted residential histories

  1996cited by this paper
• Aluminum binds to the hyperphosphorylated tau in Alzheimer's disease: a hypothesis.

  1995cited by this paper
• Defective protein folding as a basis of human disease.

  1995cited by this paper
• Components of drinking water and risk of cognitive impairment in the elderly.

  1994cited by this paper
• Aluminum promotes the aggregation of Alzheimer's amyloid beta-protein in vitro.

  1994cited by this paper
• Aluminum, Iron, and Zinc Ions Promote Aggregation of Physiological Concentrations of β‐Amyloid Peptide

  1993cited by this paper
• Laser microprobe analysis of brain aluminum in Alzheimer' disease

  1993cited by this paper
• Absence of aluminium in neuritic plaque cores in Alzheimer's disease

  1992cited by this paper
• Alzheimer's disease: the amyloid cascade hypothesis.

  1992cited by this paper
• Selective accumulation of aluminum and iron in the neurofibrillary tangles of Alzheimer's disease: A laser microprobe (LAMMA) study

  1992cited by this paper
• Aluminium administered in drinking water but not in the diet influences biopterin metabolism in the rodent.

  1992cited by this paper
• Absence of aluminium in Alzheimer's disease brain tissue: electron microprobe and ion microprobe studies.

  1991cited by this paper
• Aluminosilicates and senile plaque formation in Alzheimer's disease.

  1986cited by this paper

• Zinc-porphyrin complex as multifunctional anti-AD agent: Synthesis, X-ray single crystal analysis and activity study.

  2026cites this paper
• Machine Learning-Assisted Lanthanide Fluorescence Sensor Array Based on pH Regulation for Pattern Recognition of Metal Ions in Biological Fluids

  2025cites this paper
• Cell-specific copper dyshomeostasis mechanism in Alzheimer’s disease

  2025cites this paper
• The White Matter Integrity and Functional Connection Differences of Fornix (Cres)/Stria Terminalis in Individuals with Mild Cognitive Impairment Induced by Occupational Aluminum Exposure

  2024cites this paper
• Common and Trace Metals in Alzheimer’s and Parkinson’s Diseases

  2023cites this paper
• Functions of the Hsp90-Binding FKBP Immunophilins.

  2023cites this paper
• Panaxadiol carbamate derivatives: Synthesis and biological evaluation as potential multifunctional anti-Alzheimer agents.

  2023cites this paper
• Theoretical insights into Zn2+chelated complexes of herbacetin for the application in Alzheimer's disease

  2023cites this paper
• Repositioning and development of new treatments for neurodegenerative diseases: Focus on neuroinflammation.

  2022cites this paper
• The Molecular Basis of Memory: Remembering and Forgetting

  2022cites this paper
• Fucoidans inhibited tau interaction and cellular uptake.

  2022cites this paper
• Alteration of Biomolecular Conformation by Aluminum-Implications for Protein Misfolding Disease

  2022cites this paper
• A three-dimensional "turn-on" sensor array for simultaneous discrimination of multiple heavy metal ions based on bovine serum albumin hybridized fluorescent gold nanoclusters.

  2022cites this paper
• Role of aluminum exposure on Alzheimer’s disease and related glycogen synthase kinase pathway

  2022cites this paper
• A mechanistic survey of Alzheimer's disease.

  2021cites this paper
• Conformation Changes of Enkephalin in Coordination with Pb2+ Investigated by Gas Phase Hydrogen/Deuterium Exchange Mass Spectrometry Combined with Theoretical Calculations

  2021cites this paper
• DNA Double-Strand Breaks Induced in Human Cells by Twelve Metallic Species: Quantitative Inter-Comparisons and Influence of the ATM Protein

  2021cites this paper
• Action Mechanisms of Curcumin in Alzheimer’s Disease and Its Brain Targeted Delivery

  2021cites this paper
• Ion release characterization in phase separated borosilicate glass powders

  2020cites this paper
• Visual detection of different metal ions based on the tug of war between triangular Au nanoparticles and metal ions against mercaptans.

  2020cites this paper
• Copper imbalance in Alzheimer’s disease: Convergence of the chemistry and the clinic

  2019cites this paper
• Metal Toxicity Links to Alzheimer's Disease and Neuroinflammation.

  2019cites this paper
• Usnic acid derivatives as tau-aggregation and neuroinflammation inhibitors.

  2019cites this paper
• Bioinspired Copolymers Based Nose/Tongue-Mimic Chemosensor for Label-Free Fluorescent Pattern Discrimination of Metal Ions in Biofluids.

  2018cites this paper
• Alzheimer’s disease: How metal ions define β-amyloid function

  2017cites this paper
• Identification of a New Function of Cardiovascular Disease Drug 3-Morpholinosydnonimine Hydrochloride as an Amyloid-β Aggregation Inhibitor

  2017cites this paper
• Metal ions influx is a double edged sword for the pathogenesis of Alzheimer's disease.

  2017cites this paper
• Brain biometals and Alzheimer's disease – boon or bane?

  2017cites this paper
• Blood cadmium levels and Alzheimer’s disease mortality risk in older US adults

  2016cites this paper
• Potential Animal Models of Alzheimer Disease and Their Importance in Investigating the Pathogenesis of Alzheimer Disease

  2016cites this paper
• Modulation of Neurobehavioral and Biochemical Alterations Induced by Aluminum Chloride with Cannabis sativa Extract

  2016cites this paper
• How the imidazole ring modulates amyloid formation of islet amyloid polypeptide: A chemical modification study.

  2016cites this paper
• Alzheimer's disease due to loss of function: A new synthesis of the available data.

  2016cites this paper
• Effect of Zn(2+) ions on the assembly of amylin oligomers: insight into the molecular mechanisms.

  2016cites this paper
• Challenges in studying the structures of metal-amyloid oligomers related to type 2 diabetes, Parkinson's disease, and Alzheimer's disease

  2016cites this paper
• 19. Neurological Disorders

  2016cites this paper
• Probing oligomerization of amyloid beta peptide in silico.

  2016cites this paper
• Chronic exposure to aluminum and risk of Alzheimer's disease: A meta-analysis.

  2016cites this paper
• Protein Misfolding and Amyloid Formation in Alzheimer’s Disease

  2015cites this paper
• Functions of the Hsp90-binding FKBP immunophilins.

  2015cites this paper
• Memory restorative ability of clioquinol in copper–cholesterol-induced experimental dementia in mice

  2015cites this paper
• Effect of Aluminium and Copper on Dopamine Synthesis in Striatal Synaptosomes of Rat’s Brain

  2015cites this paper
• hronic exposure to aluminum and risk of Alzheimer ’ s disease : A eta-analysis

  2015cites this paper
• A Fluorescence Resonance Energy Transfer Assay For Monitoring α- Synclein Aggregation in a Caenorhabditis Elegans Model For Parkinson's Disease.

  2015cites this paper
• Development of a novel aluminum-free glass ionomer cement based on magnesium/strontium-silicate glasses.

  2014cites this paper
• Aluminum-Induced Amyloidogenesis and Impairment in the Clearance of Amyloid Peptides from the Central Nervous System in Alzheimer’s Disease

  2014cites this paper
• Chronic Aluminum Intake Causes Alzheimer's Disease: Applying Sir Austin Bradford Hill's Causality Criteria

  2014cites this paper
• The interactions of glycated decapeptide, the Amadori product, with copper(II) ions - a possible effect on the oxidative stress induced aggregation?

  2014cites this paper
• Effects of Zn Binding on the Structural and Dynamic Properties of Amyloid Β Peptide Associated with Alzheimer’s Disease: Asp or Glu?

  2013cites this paper
• Amyloidosis in Alzheimer's Disease: The Toxicity of Amyloid Beta (Aβ), Mechanisms of Its Accumulation and Implications of Medicinal Plants for Therapy

  2013cites this paper
• Aluminum and AlzheimerâÂÂs Disease: An Update

  2013cites this paper
• Effects of Zn2+ binding on the structural and dynamic properties of amyloid β peptide associated with Alzheimer's disease: Asp1 or Glu11?

  2013cites this paper
• The relevance of metals in the pathophysiology of neurodegeneration, pathological considerations.

  2013cites this paper
• Role of metal ions dyshomeostasis in neurodegeneration

  2013influential citation
• Analyzing the Solution State of Protein Structure, Interactions, and Ligands by Spectroscopic Methods

  2013cites this paper
• Effects of Cu2+ on aggregation behavior of poly (l-Glutamic Acid)-functionalized gold nanoparticles

  2013cites this paper
• Thermodynamic and structural characterization of an antibody gel

  2013cites this paper
• Aluminum Involvement in the Progression of Alzheimer's Disease

  2013cites this paper
• Environmental Factors Preceding Aβ40 Monomer to Oligomers and the Detection of Oligomers in Alzheimer's Disease Patient Serum

  2012cites this paper
• Structural characterization of Cu2+, Ni2+ and Zn2+ binding sites of model peptides associated with neurodegenerative diseases

  2012cites this paper
• Labile zinc-assisted biological phosphate chemosensing and related molecular logic gating interpretations.

  2012cites this paper
• Modulation of Amyloid-β Conformation by Charge State of N-Terminal Disordered Region

  2012cites this paper
• Effects of a Copper-Deficient Diet on the Biochemistry, Neural Morphology and Behavior of Aged Mice

  2012cites this paper
• Modifiers of Protein Aggregation—From Nonspecific to Specific Interactions

  2012cites this paper
• Dynamics of Zn(II) binding as a key feature in the formation of amyloid fibrils by Aβ11-28.

  2012cites this paper
• Protein‐Polyelectrolyte Complexes. How to Suppress Thermoaggregation without Noticeable Denaturing of the Protein?

  2012cites this paper
• Transgenic nematodes as a model for Parkinson's disease

  2012cites this paper
• Insights into the mechanisms of amyloid formation of Zn(II)-Ab11-28: pH-dependent zinc coordination and overall charge as key parameters for kinetics and the structure of Zn(II)-Ab11-28 aggregates.

  2012cites this paper
• Cognitive Deterioration and Associated Pathology Induced by Chronic Low-Level Aluminum Ingestion in a Translational Rat Model Provides an Explanation of Alzheimer's Disease, Tests for Susceptibility and Avenues for Treatment

  2012cites this paper
• Soluble polyelectrolyte complexes of biopolymers

  2012cites this paper
• Metal ions affect insulin-degrading enzyme activity.

  2012cites this paper
• Template induced conformational change of amyloid-β monomer.

  2012cites this paper
• Microarray analysis of gene expression profiles in human neuroblastoma cells exposed to Aβ–Zn and Aβ–Cu complexes

  2012cites this paper
• Compact conformations of α‐synuclein induced by alcohols and copper

  2011cites this paper
• Exploring the reactions of β-amyloid (Aβ) peptide 1-28 with Al(III) and Fe(III) ions.

  2011cites this paper
• Repeated-dose toxicity attributed to aluminum nanoparticles following 28-day oral administration, particularly on gene expression in mouse brain

  2011cites this paper
• Zinc, copper, and carnosine attenuate neurotoxicity of prion fragment PrP106-126.

  2011cites this paper
• Basic guidelines for the selection of polyelectrolytes that can effectively prevent thermal aggregation of enzymes without any substantial loss in their catalytic activity1

  2011cites this paper
• Beta-amyloid toxicity increases with hydrophobicity in the presence of metal ions

  2011cites this paper
• In vivo toxicity of nano-alumina on mice neurobehavioral profiles and the potential mechanisms.

  2011cites this paper
• Aluminum and Alzheimer's Disease: After a Century of Controversy, Is there a Plausible Link?

  2011influential citation
• Cholinesterases, a target of pharmacology and toxicology.

  2011cites this paper
• Zinc(II) modulates specifically amyloid formation and structure in model peptides

  2011cites this paper
• Physiological cholesterol concentration is a neuroprotective factor against β-amyloid and β-amyloid-metal complexes toxicity.

  2011cites this paper
• A two-site mechanism for the inhibition of IAPP amyloidogenesis by zinc.

  2011cites this paper
• The role of environmental exposures in neurodegeneration and neurodegenerative diseases.

  2011cites this paper
• Link between Aluminum and the Pathogenesis of Alzheimer's Disease: The Integration of the Aluminum and Amyloid Cascade Hypotheses

  2011cites this paper
• Resveratrol Acts Not through Anti-Aggregative Pathways but Mainly via Its Scavenging Properties against Aβ and Aβ-Metal Complexes Toxicity

  2011cites this paper
• Effect of cadmium ions on amyloid beta peptide 1-42 channel activity

  2011cites this paper
• Chapter 32 – Aluminum

  2011cites this paper
• Impact of Aging on Brain Structure and Function in Rodents and Canines

  2011cites this paper
• Simultaneous determination of Fe, P, Ca, Mg, Zn, and Cu in whole blood by two-jet plasma atomic emission spectrometry.

  2010cites this paper
• Strategies for the Inhibition of Protein Aggregation in Human Diseases

  2010cites this paper
• Structural changes of a protein bound to a polyelectrolyte depend on the hydrophobicity and polymerization degree of the polyelectrolyte

  2010cites this paper
• Protective Role of Melatonin on Oxidative Stress Status and RNA Expression in Cerebral Cortex and Cerebellum of AβPP Transgenic Mice After Chronic Exposure to Aluminum

  2010cites this paper
• The Role of Copper Ion and the Ubiquitin System in Neurodegenerative Disorders

  2010cites this paper
• Impaired spatial learning and unaltered neurogenesis in a transgenic model of Alzheimer's disease after oral aluminum exposure.

  2010cites this paper
• Evidence supporting a biological role for aluminum in chromatin compaction and epigenetics.

  2010cites this paper
• Aluminum in the Diet and Alzheimer's Disease: From Current Epidemiology to Possible Disease-Modifying Treatment

  2010cites this paper
• Trace Copper(II) or Zinc(II) Ions Drastically Modify the Aggregation Behavior of Amyloid-β1–42: An AFM Study

  2010cites this paper